Key takeaways
- Ozempic is approved for managing blood sugar in type 2 diabetes and reducing cardiovascular or kidney risks, while Wegovy is approved for chronic weight management.
- Both medications are available as weekly injections or daily tablets. Wegovy is typically prescribed at higher doses than Ozempic to achieve weight loss.
- Common side effects include nausea, vomiting, diarrhea, and abdominal pain. Both medications carry a boxed warning about a possible risk of thyroid cancer and may not be suitable for some people.
Ozempic and Wegovy are both prescription medications containing the active ingredient semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. While they share the same active ingredient, they are FDA-approved for different primary purposes and are available in different dosages and forms.
This article explains how Ozempic and Wegovy are alike and different.
Ozempic and Wegovy are both prescribed to help with long-term weight loss in certain people, along with diet and exercise. Wegovy is approved by the Food and Drug Administration (FDA) for this use, but this is an off-label use for Ozempic. With off-label use, doctors prescribe a drug for a purpose other than what it’s approved for.
The drugs also have other uses, as this table shows:
| Indication / Purpose | Ozempic | Wegovy |
|---|---|---|
| Long-term weight loss (in adults with obesity or overweight with related health conditions like high blood pressure or type 2 diabetes) | ✓ (off-label use) | ✓ |
| Weight loss in children (12 years and older with obesity) | — | ✓ (injection only) |
| Manage blood sugar (adults with type 2 diabetes) | ✓ | — |
| Reduce risk of cardiovascular (CV) problems (certain adults) | ✓ (in adults with CV disease and type 2 diabetes) | ✓ (in adults with CV disease with obesity or overweight) |
| Prevent kidney disease progression (adults with type 2 diabetes and chronic kidney disease) | ✓ (injection only) | — |
| Treat metabolic-associated steatohepatitis (MASH) (adults with moderate-to-advanced liver fibrosis) | — | ✓ (injection only) |
Wegovy is approved for long-term weight management in certain adults and children. In studies, most people who took Wegovy lost at least 5% of their body weight over 68 weeks. Almost half of the people who took Wegovy lost at least 15% of their body weight in that time.
Ozempic is not approved for weight loss or weight management, but doctors may prescribe it off-label for this purpose. Some people using Ozempic in clinical studies reported weight loss, but its primary indication is to help with blood sugar control.
Ozempic and Wegovy are primarily known as once-weekly subcutaneous injections, but both now also have oral tablet versions.
Injections
You inject Ozempic and Wegovy under the skin of the abdomen, thigh, or upper arm once weekly.
Ozempic uses a multidose pen where you attach a new needle for each dose. Ozempic dosages start at 0.25 mg weekly, increasing every 4 weeks to 0.5 mg, then 1 mg, and up to a maximum of 2 mg if needed for blood sugar management.
Wegovy typically uses single-dose pens with integrated needles. However, a “FlexTouch” multidose pen is also available in some countries.
Wegovy dosages start at 0.25 milligrams (mg) weekly, increasing every 4 weeks through 0.5 mg, 1 mg, and 1.7 mg, to a maintenance dose of 2.4 mg. For certain adults, it may be escalated further to 7.2 mg.
Tablets
You take Ozempic and Wegovy tablets by mouth on an empty stomach in the morning with no more than 4 ounces of plain water. You must wait at least 30 minutes before eating, drinking, or taking other oral medications.
Ozempic tablets are available in 1.5 mg, 4 mg, and 9 mg strengths. Wegovy tablets are available in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths.
Ozempic and Wegovy may cause side effects ranging from mild to serious.
Mild side effects
Mild side effects include:
- nausea and vomiting
- abdominal pain or bloating
- diarrhea
- constipation
- indigestion
- burping or gas
- fatigue (low energy)
- dizziness
- headache
- mild injection site reaction
Serious side effects
- possible risk of thyroid cancer (boxed warning)
- pancreatitis (swelling in the pancreas)
- kidney injury or failure due to dehydration
- gallbladder problems, such as gallstones
- low blood sugar
- increased heart rate
- severe allergic reaction
To learn about your risk for serious side effects from Ozempic or Wegovy, talk with your doctor or pharmacist.
Ozempic and Wegovy are not currently available as generics. A generic drug is an exact copy of the active ingredient in a brand-name medication. Generic drugs tend to cost significantly less than the brand-name drug they are modeled on.
What you’ll pay for Ozempic and Wegovy may depend on several things, including:
- your treatment plan
- whether you have health insurance
- whether your insurance covers the drugs
- the pharmacy you use
You may be able to find drug coupons on prescription discount websites that can reduce the cost of your medication. These coupons cannot be used with insurance copays or benefits, but the discounted price may be lower than what you would pay through insurance.
Optum Perks is owned by RVO Health. By clicking on this link, we may receive a commission. Learn more.
Ozempic and Wegovy may not be right for you if you have certain medical conditions or other factors that affect your health.
Boxed warning
Both Ozempic and Wegovy have a boxed warning about the risk of thyroid tumors and thyroid cancer. A boxed warning is the most serious warning from the Food and Drug Administration (FDA).
In animal studies, semaglutide (the active drug in Ozempic and Wegovy) has been shown to cause thyroid tumors and thyroid cancer. Doctors don’t know if it can cause thyroid cancers in people.
Due to the possible risk, your doctor will likely not prescribe Ozempic or Wegovy if you have a higher risk of thyroid cancer. This could be because you or a family member has had thyroid cancer before. Or it could be that you have a genetic condition called multiple endocrine neoplasia syndrome type 2 (MEN2), which raises your risk of thyroid cancer.
If you’re prescribed Ozempic or Wegovy, tell your doctor right away if you develop a lump in your neck, hoarseness that doesn’t go away, or have trouble swallowing or breathing. These could be signs of thyroid cancer.
Other warnings
In addition to boxed warnings, Ozempic and Wegovy have other warnings. Before starting treatment, talk with your doctor if any of the following conditions or health factors apply to you:
- previous allergic reaction to either drug or any of its ingredients
- pregnant or planning to become pregnant
- breastfeeding or planning to breastfeed
- previous pancreatitis or another problem with your pancreas
- history of diabetic retinopathy
- kidney problem
- gastroparesis or another condition that may slow digestion
- planned surgery that will require sedation or general anesthesia
- depression or other mental health conditions
It’s possible to switch between Ozempic and Wegovy, or between injection and tablet forms, but you must do this as directed by a doctor.
For weight loss, Ozempic and Wegovy are used at slightly different doses, and your body may respond differently to the two drugs.
Don’t switch drugs or stop your current treatment unless your doctor recommends it.
Ozempic and Wegovy both contain semaglutide but are approved for different purposes. Ozempic is approved for type 2 diabetes and related cardiovascular or kidney risks. Wegovy is approved for chronic weight management and cardiovascular risk reduction in overweight or obese adults.
Both medications are available as weekly injections or daily tablets, but Wegovy is typically prescribed at significantly higher doses than Ozempic to achieve weight loss.
Disclaimer: While Healthline strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.



